Open Access. Powered by Scholars. Published by Universities.®
Metastatic breast cancer;; long survival;; trastuzumab;; CHEMOTHERAPY;; DYSFUNCTION;; PROGRESSION;; REMISSION;; SURVIVAL;; PATIENT;; TRIALS;; Biotechnology & Applied Microbiology;; Oncology
Articles 1 - 1 of 1
Full-Text Articles in Medicine and Health Sciences
More Than 9 Years Of Continuous Trastuzumab Treatment In Metastatic Breast Cancer Without Cardiac Toxicity: A Case Report And Literature Review, F. Badulescu, A. Badulescu, D. Paul, C. F. Popescu, C. Florescu
More Than 9 Years Of Continuous Trastuzumab Treatment In Metastatic Breast Cancer Without Cardiac Toxicity: A Case Report And Literature Review, F. Badulescu, A. Badulescu, D. Paul, C. F. Popescu, C. Florescu
Journal Articles
The main concern of long-term use of trastuzumab remains its association with potential cardiac side effects. Although these side effects are real, they are probably overemphasized. We report the case of a woman with metastatic breast cancer, who is currently in complete remission, and who received trastuzumab continuously for more than 9 years, without any significant cardiac toxicity.